Clinical trial
The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 (PCSK-9) Level in Patients After Coronary Bypass Surgery
NCT02674659 is registered in ClinicalTrials.gov with National Cardiovascular Center Harapan Kita Hospital Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 (PCSK-9) Level in Patients After Coronary Bypass Surgery
- Lead sponsor
- National Cardiovascular Center Harapan Kita Hospital Indonesia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2016
- Completion date
- December 18, 2016
- Enrollment
- 87 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.